![](/img/cover-not-exists.png)
Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: A 12-month randomized, prospective, open- label trial
Dawn M. Torres, Frances J. Jones, Janet C. Shaw, Christopher D. Williams, John A. Ward, Stephen A. HarrisonVolume:
54
Year:
2011
Language:
english
Pages:
9
DOI:
10.1002/hep.24558
File:
PDF, 393 KB
english, 2011